Amyotrophic lateral sclerosis: a lesson in translation
-
Published:2024-07
Issue:7
Volume:23
Page:651-653
-
ISSN:1474-4422
-
Container-title:The Lancet Neurology
-
language:en
-
Short-container-title:The Lancet Neurology
Reference9 articles.
1. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis;Goutman;Lancet Neurol,2022
2. Trial of antisense oligonucleotide tofersen for SOD1 ALS;Miller;N Engl J Med,2022
3. Trial of sodium phenylbutyrate-taurursodiol for amyotrophic lateral sclerosis;Paganoni;N Engl J Med,2020
4. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial;Abe;Lancet Neurol,2017
5. Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial;Benetar;Lancet Neurol,2024